Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

young autologous tumor-infiltrating lymphocytes

A preparation of autologous young tumor-infiltrating lymphocytes (TILs), that are isolated from the patient’s tumor tissue and minimally cultured ex vivo, with potential antineoplastic and immunomodulating activities. Upon re-administration of the young TILs, the TILs re-infiltrate the tumor, recognize the tumor cells and initiate tumor cell lysis. This inhibits tumor cell growth.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	therapeutic young autologous TILs young autologous TIL young autologous TILs young autologous tumor infiltrating lymphocytes

young autologous tumor-infiltrating lymphocytes

Search NCI's Drug Dictionary